BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17560929)

  • 21. Sentinel lymph node mapping in colorectal malignancy.
    El-Khoury T; Solomon M
    ANZ J Surg; 2008 Sep; 78(9):733-4. PubMed ID: 18844897
    [No Abstract]   [Full Text] [Related]  

  • 22. Lymph node assessment in cervical cancer: prognostic and therapeutic implications.
    Gien LT; Covens A
    J Surg Oncol; 2009 Mar; 99(4):242-7. PubMed ID: 19048600
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upstaging benefits and accuracy of sentinel lymph node mapping in colorectal adenocarcinoma nodal staging.
    Quadros CA; Lopes A; Araujo I; Fregnani JH; Fahel F
    J Surg Oncol; 2008 Oct; 98(5):324-30. PubMed ID: 18618578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Intraoperative staging of colorectal tumors].
    Abdurakhmonov IuB; Mel'nikov OR; Egorenkov VV; Moiseenko VM
    Vopr Onkol; 2007; 53(2):210-4. PubMed ID: 17663177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of false-negative sentinel lymph node biopsy on survival in patients with cutaneous melanoma.
    Caracò C; Marone U; Celentano E; Botti G; Mozzillo N
    Ann Surg Oncol; 2007 Sep; 14(9):2662-7. PubMed ID: 17597345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications].
    Kruit WH;
    Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years.
    Domènech A; Benitez A; Bajén MT; Pla MJ; Gil M; Martín-Comín J
    Oncology; 2007; 72(1-2):27-32. PubMed ID: 17998787
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lymphadenectomy in stomach and colorectal carcinoma].
    Siewert JR; Lange J
    Dtsch Med Wochenschr; 1990 Mar; 115(10):391-4. PubMed ID: 2178899
    [No Abstract]   [Full Text] [Related]  

  • 29. [A decade of sentinel lymph node biopsy for breast cancer: time for adaptations].
    Wobbes T
    Ned Tijdschr Geneeskd; 2008 Jan; 152(1):10-2. PubMed ID: 18240753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lymphadenectomy in elective and urgency surgery for resective colorectal cancer.
    Scabini S; Rimini E; Romairone E; Scordamaglia R; Pertile D; Ferrando V
    Minerva Chir; 2009 Apr; 64(2):183-8. PubMed ID: 19365318
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An update on the surgical management of colon cancer.
    McKenzie S; Barnes S; Schwartz R
    Curr Surg; 2005; 62(3):313-8. PubMed ID: 15890214
    [No Abstract]   [Full Text] [Related]  

  • 32. [Potential immunologic consequences of lymph node dissection in colorectal cancer].
    Pagès F; Berger A; Zinzindohoué F; Kirilovsky A; Galon J; Fridman WH
    J Chir (Paris); 2008 Dec; 145 Spec no. 4():12S6-12S12. PubMed ID: 19194351
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sentinel lymph node biopsy in cutaneous melanoma: a case-control study.
    Koskivuo I; Talve L; Vihinen P; Mäki M; Vahlberg T; Suominen E
    Ann Surg Oncol; 2007 Dec; 14(12):3566-74. PubMed ID: 17924169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sentinel node for gastrointestinal malignancies.
    Kitagawa Y; Saha S; Kubo A; Kitajima M
    Surg Oncol Clin N Am; 2007 Jan; 16(1):71-80. PubMed ID: 17336237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axillary recurrence rate after tumour negative and micrometastatic positive sentinel node procedures in breast cancer patients, a population based multicenter study.
    Bulte CS; van der Heiden-van der Loo M; Hennipman A
    Eur J Surg Oncol; 2009 Jan; 35(1):25-31. PubMed ID: 18640809
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.
    Zavagno G; De Salvo GL; Scalco G; Bozza F; Barutta L; Del Bianco P; Renier M; Racano C; Carraro P; Nitti D;
    Ann Surg; 2008 Feb; 247(2):207-13. PubMed ID: 18216523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minimal axillary lymph node involvement in breast cancer has different prognostic implications according to the staging procedure.
    Montagna E; Viale G; Rotmensz N; Maisonneuve P; Galimberti V; Luini A; Intra M; Veronesi P; Mazzarol G; Pruneri G; Renne G; Torrisi R; Cardillo A; Cancello G; Goldhirsch A; Colleoni M
    Breast Cancer Res Treat; 2009 Nov; 118(2):385-94. PubMed ID: 19562480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The evolution of lymph node assessment in breast cancer.
    Quan ML; McCready D
    J Surg Oncol; 2009 Mar; 99(4):194-8. PubMed ID: 19021226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A nonrandomized follow-up comparison between standard axillary node dissection and sentinel node biopsy in breast cancer.
    Konstantiniuk P; Schrenk P; Reitsamer R; Koeberle-Wuehrer R; Tausch C; Roka S; Riedl O; Poestlberger S; Hecke D; Janauer M; Haid A
    Breast; 2007 Oct; 16(5):520-6. PubMed ID: 17566737
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.